
Antisense Therapeutics Ltd
ASX:ANP

Fundamental Analysis


Revenue & Expenses Breakdown
Antisense Therapeutics Ltd
Balance Sheet Decomposition
Antisense Therapeutics Ltd
Current Assets | 12.7m |
Cash & Short-Term Investments | 11m |
Receivables | 1.7m |
Other Current Assets | 66.5k |
Non-Current Assets | 150.8k |
PP&E | 150.8k |
Free Cash Flow Analysis
Antisense Therapeutics Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Antisense Therapeutics Ltd
Revenue
|
384.9k
AUD
|
Operating Expenses
|
-11.8m
AUD
|
Operating Income
|
-11.4m
AUD
|
Other Expenses
|
380
AUD
|
Net Income
|
-11.4m
AUD
|
ANP Profitability Score
Profitability Due Diligence
Antisense Therapeutics Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Score
Antisense Therapeutics Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
ANP Solvency Score
Solvency Due Diligence
Antisense Therapeutics Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Score
Antisense Therapeutics Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ANP Price Targets Summary
Antisense Therapeutics Ltd
Dividends
Current shareholder yield for ANP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?